Combination therapy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue SUPPL. 1, 2005, Pages 89-93

  Ingemarsson, Ingemar ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CEFUROXIME; CORTICOSTEROID; METRONIDAZOLE; OXYTOCIN ANTAGONIST; PROSTAGLANDIN SYNTHASE INHIBITOR; SULINDAC; TERBUTALINE; ANTIINFECTIVE AGENT; ARGIPRESTOCIN; DRUG DERIVATIVE; UTERUS SPASMOLYTIC AGENT;

ADULT; BLOOD PH; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; DUCTUS ARTERIOSUS OBLITERATION; EVIDENCE BASED MEDICINE; FEMALE; FETUS; HUMAN; MEMBRANE RUPTURE; NEWBORN INTENSIVE CARE; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; SEPSIS; SIDE EFFECT; SWEDEN; TACHYCARDIA; TREMOR; UMBILICAL CORD BLOOD; UTERINE CERVIX; ARTICLE; DRUG COMBINATION; GESTATIONAL AGE; INTRAVENOUS DRUG ADMINISTRATION; PREGNANCY; PREGNANCY OUTCOME; SECOND TRIMESTER PREGNANCY; SURVIVAL;

ADRENERGIC BETA-AGONISTS; ANTI-BACTERIAL AGENTS; CYCLOOXYGENASE INHIBITORS; DRUG THERAPY, COMBINATION; FEMALE; GESTATIONAL AGE; HUMANS; INFUSIONS, INTRAVENOUS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; SULINDAC; SURVIVAL ANALYSIS; TERBUTALINE; TOCOLYTIC AGENTS; VASOTOCIN;

EID: 18344387791     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2005.00593.x     Document Type: Conference Paper

References (20)

1. Medical Birth Register, National Board of Health and Welfare, Sweden, 2001-2002.
2. Hack M, Fanaroff AA. Outcomes of extremely low birthweight and gestational age in the 1990s. Semin Neonatol 2000;5:89-106.
3. Lorentz M. The outcome of extreme prematurity. Semin Perinatol 2001;5:348-359.
4. Yu V, Doyle L. Survival and disability in babies less than 26 weeks' gestation. Semin Neonatol 1996;1:257-265.
5. Finnström O, Olausson PO, Sedin G, et al. The Swedish national prospective study on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to level of care. Acta Pediatr 1997;86:503-511.
6. Holmgren PA, Högberg U. The very early preterm infant - a population-based study. Acta Obstet Gynecol Scand 2001;80:525-531.
7. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000:CD000065.
8. Slattery MS, Morrison JJ. Preterm delivery. Lancet 2002;360:1489-1497.
9. Ingemarsson I, Arulkumaran S, Kottegoda SR. Complications of beta-mimetic therapy in preterm labour. Aust N Z J Obstet Gynaecol 1985;25:182-189.
10. Lamont RF. The pathophysiology of pulmonary oedema with the use of beta-agonists. Br J Obstet Gynaecol 2000;107:439-444.
11. The Worldwide Atosiban vs Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. Br J Obstet Gynaecol 2001;108:133-142.
12. Rasanen J, Jouppila P. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study. Am J Obstet Gynecol 1995;173:20-25.
13. Carlan SJ, O'Brien WF, O'Leary TD, Mastrogiannis D. Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labor. Obstet Gynecol 1992;79:223-228.
14. Loudon JA, Groom KM, Bennett PR. Prostaglandin inhibitors in pre-term labour. Best Pract Res Clin Obstet Gynaecol 2003;17:731-744.
15. Stubblefield PG. Pulmonary edema occurring after therapy with dexamethasone and terbutaline for premature labor. Am J Obstet Gynecol 1978;132:341-342.
16. Lamont RF. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth. Br J Obstet Gynaecol 2003;110(Suppl. 20):71-75.
17. King J, Flenady V. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev 2002: CD000246.
18. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. Lancet 2001;357:989-994.
19. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 2001;357:979-988.
20. Herbst A, Wide-Swensson D, Ingemarsson I. Significant delay of birth in advanced preterm labour at 23 gestational weeks with an oxytocin antagonist. Eur J Obstet Gynecol Reprod Biol 2003;108:109-110.